A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2021
Historique:
received: 13 05 2020
accepted: 12 10 2020
pubmed: 22 10 2020
medline: 23 1 2021
entrez: 21 10 2020
Statut: ppublish

Résumé

Suppressing infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will probably require the rapid identification and isolation of individuals infected with the virus on an ongoing basis. Reverse-transcription polymerase chain reaction (RT-PCR) tests are accurate but costly, which makes the regular testing of every individual expensive. These costs are a challenge for all countries around the world, but particularly for low-to-middle-income countries. Cost reductions can be achieved by pooling (or combining) subsamples and testing them in groups

Identifiants

pubmed: 33086375
doi: 10.1038/s41586-020-2885-5
pii: 10.1038/s41586-020-2885-5
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-280

Commentaires et corrections

Type : ErratumIn

Références

Dorfman, R. The detection of defective members of large populations. Ann. Math. Stat. 14, 436–440 (1943).
doi: 10.1214/aoms/1177731363
Hwang, F. K. A method for detecting all defective members in a population by group testing. J. Am. Stat. Assoc. 67, 605–608 (1972).
doi: 10.1080/01621459.1972.10481257
Allemann, A. in Information Theory, Combinatorics, and Search Theory. Lecture Notes in Computer Science Vol. 7777 (Aydinian, H. et al.) 569–596 (Springer, 2013).
Aldridge, M., Johnson, O. & Scarlett, J. Group testing: an information theory perspective. Found. Trends Commun. Inf. Theory 15, 196–392 (2019).
doi: 10.1561/0100000099
Ghosh, S. et al. A compressed sensing approach to group-testing for COVID-19 detection. Preprint at https://arxiv.org/abs/2005.07895 (2020).
Heng, B. W. & Scarlett, J. Non-adaptive group testing in the linear regime: strong converse and approximate recovery. Preprint at https://arxiv.org/abs/2006.01325 (2020).
Broder, A. Z. & Kumar, R. A note on double pooling tests. Preprint at https://arxiv.org/abs/2004.01684 (2020).
Arevalo-Rodriguez, I. et al. False negative results of initial RT-PCR assays for COVID-19: a systematic review. Preprint at https://doi.org/10.1101/2020.04.16.20066787 (2020).
Lohse, S. et al. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect. Dis. 20, 1231–1232 (2020).
doi: 10.1016/S1473-3099(20)30362-5 pubmed: 32530425 pmcid: 7194818
Yelin, I. et al. Evaluation of COVID-19 RT-qPCR test in multi sample pools. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa531 (2020).
Shental, N. et al. Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers. Sci. Adv. 6, eabc5961 (2020).
doi: 10.1126/sciadv.abc5961 pubmed: 32917716 pmcid: 7485993
Medicare. Medicare Administrative Contractor (MAC) COVID-19 Test Pricing. https://www.cms.gov/files/document/mac-covid-19-test-pricing.pdf (2020).
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, 2000045 (2020).
pmcid: 6988269
Sanche, S. et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1470–1477 (2020).
doi: 10.3201/eid2607.200282 pubmed: 32255761 pmcid: 7323562
Office of National Statistics. Coronavirus (COVID-19) Infection Survey pilot: England and Wales, 4 September 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/englandandwales4september2020 (UK Department of Health & Social Care, 2020).
Pouwels, K. B. et al. Community prevalence of SARS-CoV-2 in England: results from the ONS Coronavirus Infection Survey Pilot. Preprint at https://doi.org/10.1101/2020.07.06.20147348 (2020).
Office of National Statistics. COVID-19 Infection Survey (Pilot): Methods and Further Information: Test Sensitivity and Specificity. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/methodologies/covid19infectionsurveypilotmethodsandfurtherinformation#test-sensitivity-and-specificity (UK Department of Health & Social Care, 2020).
Office of National Statistics. Weekly Statistics for NHS Test and Trace (England) and coronavirus testing (UK): 27 August to 2 September. Annex Table 1: People newly tested for COVID-19 under Pillars 1 and 2, England. https://www.gov.uk/government/publications/nhs-test-and-trace-england-and-coronavirus-testing-uk-statistics-27-august-to-2-september-2020/weekly-statistics-for-nhs-test-and-trace-england-and-coronavirus-testing-uk-27-august-to-2-september#annex-table-1 (UK Department of Health & Social Care, 2020).
Reijns M. A. M. et al. A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection. Preprint at https://doi.org/10.1101/2020.07.14.20154005 (2020).
Wölfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469 (2020).
doi: 10.1038/s41586-020-2196-x pubmed: 32235945
Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26, 1200–1204 (2020).
doi: 10.1038/s41591-020-0965-6 pubmed: 32555424
Watson, J., Whiting, P. F. & Brush, J. E. Interpreting a covid-19 test result. Br. Med. J. 369, m1808 (2020).
doi: 10.1136/bmj.m1808
Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D. & Lessler, J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 by time since exposure. Ann. Intern. Med. 173, 262–267 (2020)
doi: 10.7326/M20-1495 pubmed: 32422057
Jaafar, R. et al. Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa1491 (2020).
Service, R. F. One number could help reveal how infectious a COVID-19 patient is. Should test results include it? Science https://www.sciencemag.org/news/2020/09/one-number-could-help-reveal-how-infectious-covid-19-patient-should-test-results (2020).
Afshordi, N., Holder, B., Bahrami, M. & Lichtblau, D. Diverse local epidemics reveal the distinct effects of population density, demographics, climate, depletion of susceptibles, and intervention in the first wave of covid-19 in the United States. Preprint at https://arxiv.org/abs/2007.00159 (2020).

Auteurs

Leon Mutesa (L)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Pacifique Ndishimye (P)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
African Institute for Mathematical Sciences, Kigali, Rwanda.

Yvan Butera (Y)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Jacob Souopgui (J)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Université Libre de Bruxelles, Gosselies, Belgium.

Annette Uwineza (A)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Robert Rutayisire (R)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Ella Larissa Ndoricimpaye (EL)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Emile Musoni (E)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Nadine Rujeni (N)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Thierry Nyatanyi (T)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Edouard Ntagwabira (E)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Muhammed Semakula (M)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Clarisse Musanabaganwa (C)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Daniel Nyamwasa (D)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Maurice Ndashimye (M)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
African Institute for Mathematical Sciences, Kigali, Rwanda.

Eva Ujeneza (E)

African Institute for Mathematical Sciences, Kigali, Rwanda.

Ivan Emile Mwikarago (IE)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Claude Mambo Muvunyi (CM)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Jean Baptiste Mazarati (JB)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Sabin Nsanzimana (S)

Rwanda Joint Task Force COVID-19, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.

Neil Turok (N)

African Institute for Mathematical Sciences, Kigali, Rwanda. Neil.Turok@ed.ac.uk.
School of Physics and Astronomy, University of Edinburgh, Edinburgh, UK. Neil.Turok@ed.ac.uk.
Perimeter Institute for Theoretical Physics, Waterloo, Ontario, Canada. Neil.Turok@ed.ac.uk.

Wilfred Ndifon (W)

African Institute for Mathematical Sciences, Kigali, Rwanda. wndifon@nexteinstein.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH